A Multi-center, Randomized, Double-blind, Vehicle-controlled, Parallel-group Comparison Trial to Assess the Efficacy and Safety of OPA-15406 Ointment in Patients With Atopic Dermatitis

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223317

Enrollment

180

Registered

2016-09-08

Start date

2016-09-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Interventions

investigational material(s) Generic name etc : 0.3% and 1% OPA-15406 Ointment INN of investigational material : Therapeutic category code : 269 Other agents for epidermis Dosage and Administration fo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosis of atopic dermatitis based on the criteria of Hanifin and Rajka

Exclusion criteria

Exclusion criteria: - Subjects who have an atopic dermatitis or contact dermatitis flare-up defined as a sudden intensification of atopic dermatitis. - Subjects who have an active viral skin infection. - Subjects with a current or history of malignancy.

Design outcomes

Primary

Measure	Time frame
IGA	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026